THE Ministry of Health (MoH) in a press release warned the public to not take three types of health products withdrawn from the market by National Pharmaceutical Control Bureau, Malaysia after they are found to be adulterated with undeclared potent western medicines.
These health products are not registered in Malaysia and found to contain false information on their labels.
Unsupervised long-term consumption of potent corticosteroids such as Dexamethasone can cause increased blood glucose levels, leading to diabetes, high blood pressure, cataracts, muscular and bone disorders, and an increased risk of infections.
Long term use of corticosteroids can also lead to Cushing’s syndrome which is characterised by a round face or ‘moon face’, and upper body obesity with thin limbs.
Consumers who have taken high doses of steroids over a prolonged period of time may suffer from withdrawal symptoms which include fatigue, muscle and joint pain, fever, low blood sugar, low blood pressure and dehydration.
The MoH has not issued any approval for the importation and sale of the product.
Following these findings, the product is not allowed to be imported and sold in Brunei.
Members of the public involved in the retailing (including online retailing such as through Facebook) of these products are reminded that it is an offence under the Poisons Act 1956 to sell any product containing any substance controlled under the said act and the penalty for such an offence upon conviction, is a fine of $8,000 or six months’ imprisonment, the press release stated.
If a person commits an act that amounts to such a degree of negligence so as to endanger or be likely to endanger human life, then such person shall be guilty of an offence which carries a penalty of a fine of $16,000 and 12 months’ imprisonment.
Members of the public who have purchased or used these products are advised to stop using them immediately. They should consult a medical practitioner if they experience any adverse reactions or feel unwell as a result of using these products.
The Ministry of Health would also like to call upon the public for their cooperation to report to the Pharmacy Enforcement Section if any of these products are still found on the market in this country.
For further information and communication, the public may contact the Pharmacy Enforcement Section at 239329 or e-mail firstname.lastname@example.org or go directly to the first floor of Department of Pharmaceutical Services’ Building at Kg Madaras.